We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.64B
AUM Growth
-$812M
Cap. Flow
-$958M
Cap. Flow %
-20.66%
Top 10 Hldgs %
24.73%
Holding
580
New
151
Increased
91
Reduced
112
Closed
186

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.01%
2 Technology 13.11%
3 Industrials 11.74%
4 Consumer Discretionary 11.63%
5 Communication Services 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAGE
301
DELISTED
Sage Therapeutics
SAGE
$603K 0.01%
20,000
GPOR
302
DELISTED
Gulfport Energy Corp.
GPOR
$582K 0.01%
18,626
-27,367
-60% -$828K
PRTK
303
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$556K 0.01%
+40,000
New +$589K
SCYX icon
304
SCYNEXIS
SCYX
$53.9M
$542K 0.01%
+3,125
New +$884K
MOBL
305
DELISTED
MobileIron, Inc.
MOBL
$535K 0.01%
175,314
+41,694
+31% +$150K
MPC icon
306
Marathon Petroleum
MPC
$84.2B
$531K 0.01%
+14,000
New +$514K
NNN icon
307
NNN REIT
NNN
$8.98B
$517K 0.01%
+10,000
New +$464K
CTRA
308
DELISTED
Coterra Energy
CTRA
$515K 0.01%
20,000
TYC
309
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$500K 0.01%
+124,723
New +$5.23M
REI icon
310
Ring Energy
REI
$344M
$494K 0.01%
+56,029
New +$419K
TEN
311
Tsakos Energy Navigation Ltd
TEN
$1.17B
$469K 0.01%
+20,000
New +$589K
O icon
312
Realty Income
O
$59.3B
$464K 0.01%
+6,897
New +$419K
OXFD
313
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$456K 0.01%
50,705
-5,595
-10% -$54.8K
ADMA icon
314
ADMA Biologics
ADMA
$2.21B
$446K 0.01%
75,000
+40,000
+114% +$280K
TESO
315
DELISTED
Tesco Corp
TESO
$430K 0.01%
+64,337
New +$498K
GM icon
316
CALL
General Motors
GM
$76.9B
$426K 0.01%
29,454
-2,000,000
-99% -$60.7M
RPTP
317
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$403K 0.01%
75,000
+55,274
+280% +$283K
MTDR icon
318
Matador Resources
MTDR
$6.15B
$396K 0.01%
20,000
-98,000
-83% -$2.11M
NVRI icon
319
Enviri
NVRI
$633M
$381K 0.01%
57,310
-663,684
-92% -$4.32M
IVTY
320
DELISTED
Invuity, Inc
IVTY
$381K 0.01%
40,000
-35,000
-47% -$243K
MDR
321
CALL
DELISTED
McDermott International
MDR
$368K 0.01%
216,667
CLCD
322
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$368K 0.01%
44,994
-45,200
-50% -$304K
CHK
323
DELISTED
Chesapeake Energy Corporation
CHK
$360K 0.01%
+420
New +$403K
FOLD
324
DELISTED
Amicus Therapeutics
FOLD
$324K 0.01%
+59,387
New +$415K
FCX icon
325
CALL
Freeport-McMoran
FCX
$97.3B
$320K 0.01%
+350,000
New +$3.88M

Similar funds

UBS O'Connor's Q2 2016 Portfolio in Review

As of Q2 2016, UBS O'Connor held 580 positions worth $4.64B, down 15% from $5.45B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

UBS O'Connor withdrew a net $958M in Q2 2016, closing 186 positions and reducing 112 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, UBS O'Connor opened a new position in LinkedIn Corporation worth $229M.

  • UBS O'Connor's largest Q2 2016 buy was LinkedIn Corporation: 1,210,490 shares worth $229M.
  • UBS O'Connor added most to EMC CORPORATION in Q2 2016, an estimated $79.3M increase.
  • UBS O'Connor's biggest Q2 2016 reduction was Charles Schwab, cutting an estimated $79.9M.
  • UBS O'Connor fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $122M.
  • UBS O'Connor's ten largest holdings make up 25% of its $4.64B portfolio in Q2 2016.
  • UBS O'Connor opened 151 new positions and closed 186 in Q2 2016.
  • UBS O'Connor's portfolio value fell 15% quarter-over-quarter to $4.64B.

Based on UBS O'Connor's 13F filing for Q2 2016, filed 12 Aug 2016.